For the Inventor, By the Inventor

Enter assignee name

Needham, MA, United States of America

Verastem, Inc.

USPTO Granted Patents = 13

% Expired Patents = 46.2

CIPO Patents = 4

EPO Patents = 7

Trademarks = 6

Forward Citations = 20

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Jonathan A Pachter (4 out of 5 patents)

Meredith Williams (4 out of 10 patents)

DiZhong Chen (2 out of 11 patents)

4. Jennifer E Ring (2 out of 2 patents)

5. David T Weaver (2 out of 2 patents)

6. Yan Wang (2 out of 2 patents)

7. Farzaneh Seyedi (2 out of 7 patents)

8. Qunli Xu (2 out of 3 patents)

9. Winnie Tam (2 out of 2 patents)

10. Harish K Nagaraj (2 out of 2 patents)

11. Michael Luzzio (1 out of 54 patents)

12. Andrew Xian Chen (1 out of 37 patents)

13. Hui-Yin Li (1 out of 34 patents)

14. Yixiong Lei (1 out of 1 patent)

15. Carl Henry Behrens (1 out of 13 patents)

13 patents: Sort by Forward Citations

1. 12509450 - Solid forms of a dual RAF/MEK inhibitor (2025-12-30),

2. 11873296 - Solid forms of a dual RAF/MEK inhibitor (2024-01-16),

3. 11564927 - Therapeutic compositions, combinations, and methods of use (2023-01-31),

4. 10532056 - Therapeutic compositions, combinations, and methods of use (2020-01-14),

5. 10406158 - Methods and compositions for treating abnormal cell growth (2019-09-10),

6. 9962385 - Methods and compositions for treating abnormal cell growth (2018-05-08),

7. 9505719 - Synthesis and use of kinase inhibitors (2016-11-29),

8. 9375402 - Oral formulations of kinase inhibitors (2016-06-28),

9. 9138437 - Pyrimidine substituted purine compounds as kinase (S) inhibitors (2015-09-22),

10. 8754080 - Pyrimidine substituted purine compounds as kinase (S) inhibitors (2014-06-17),

11. 8722884 - Pyrimidine derivatives for the treatment of abnormal cell growth (2014-05-13),

12. 8609838 - Pyrimidine substituted purine derivatives (2013-12-17),

13. 8247410 - Pyrimidine substituted purine derivatives (2012-08-21),

Verastem, Inc. is a biopharmaceutical company focused on discovering and developing drugs to improve the survival and outcomes of cancer patients. They utilize their proprietary research technologies to identify novel compounds that target cancer stem cells, with the aim of providing innovative treatment options. Verastem is committed to advancing therapies that address significant unmet medical needs in oncology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#14 in Needham, MA

#1,441 in Massachusetts

#23,808 in US

#44,950 in the World

Needham, MA, United States of America

Verastem, Inc.

Forward Citations = 20

21 inventors:

Jonathan A Pachter (4 out of 5 patents)

Meredith Williams (4 out of 10 patents)

DiZhong Chen (2 out of 11 patents)

4. Jennifer E Ring (2 out of 2 patents)

5. David T Weaver (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…